Home LiteratureArticle Details
PMID: 6096286 Published · ppublish English Clinical Trial Journal Article Research Support, U.S. Gov't, P.H.S.

Bisantrene solubility and skin toxicity studies: efficacy of sodium bicarbonate as a local ulceration antidote.

Investigational new drugs ·Vol. 2 ·No. 4 ·1984-00-00 ·Pages 351-7

Dorr RT, Peng YM, Alberts DS

Abstract

Bisantrene solubility and skin toxicity were studied in mice given intraperitoneal (IP) and intradermal (ID) drug respectively. Bisantrene (1 mg/ml) in 5% dextrose readily precipitated in the mouse peritoneum. The admixture of bisantrene into various lipophilic solvents did not reduce drug precipitation in vivo in the mouse or in vitro in human plasma at 37 degrees C. Drug stability studies using high performance liquid chromatography (HPLC) showed markedly reduced bisantrene stability at alkaline pH. Bisantrene skin toxicity in BALB/c mice was characterized by ulceration which persisted for up to four months after ID injection. Skin toxicity was consistently reduced by dilute sodium bicarbonate injection into the bisantrene extravasation site. Three clinical extravasation cases treated with sodium bicarbonate showed no bisantrene ulceration. Ineffective local antidotes included sodium cromolyn, N-acetylcysteine, hydrocortisone, and heat (which appeared to increase toxicity).

MeSH Terms
Aged Animals Anthracenes/adverse effects,therapeutic use,toxicity Antibiotics, Antineoplastic/adverse effects,therapeutic use,toxicity Bicarbonates/therapeutic use Chromatography, High Pressure Liquid/methods Clinical Trials as Topic Drug Incompatibility Drug Stability Erythema/chemically induced,drug therapy Female Humans Hydrogen-Ion Concentration Male Mice Mice, Inbred BALB C Mice, Inbred DBA Skin Ulcer/drug therapy Sodium Bicarbonate Solubility
Chemicals
Anthracenes Antibiotics, Antineoplastic Bicarbonates bisantrene Sodium Bicarbonate
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Dorr R T
Peng Y M
Alberts D S
References (9)
9 references, click to expand
  1. Experimental model of doxorubicin extravasation in the mouse.
    J Pharmacol Methods. 1980 Nov;4(3):237-50 PMID: 7442269
  2. Disposition of bisantrene in humans and rabbits: evidence for intravascular deposition of drug as a cause of phlebitis.
    Cancer Res. 1983 Feb;43(2):925-9 PMID: 6848203
  3. Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.
    Cancer Res. 1982 Mar;42(3):1170-5 PMID: 7037174
  4. Phase I clinical trial of 9,10-anthracene dicarboxaldehyde (Bisantrene) administered in a five-day schedule.
    Cancer Res. 1982 Jan;42(1):354-8 PMID: 7053862
  5. Activity of 9-10 anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone]dihydrochloride (CL216,942) in a human tumor cloning system. Leads for phase II trials in man.
    Cancer Chemother Pharmacol. 1981;6(2):141-4 PMID: 7307232
  6. The limited role of corticosteroids in ameliorating experimental doxorubicin skin toxicity in the mouse.
    Cancer Chemother Pharmacol. 1980;5(1):17-20 PMID: 7460191
  7. High performance liquid chromatography of a new anticancer drug, ADCA--physicochemical properties and pharmacokinetics.
    Life Sci. 1981 Jul 27;29(4):361-9 PMID: 7278493
  8. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.
    Cancer Chemother Rep. 1966 May;50(4):219-44 PMID: 4957125
  9. Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (CL216,942).
    Cancer Res. 1981 Aug;41(8):3118-21 PMID: 6265075
Article Info
Journal
Investigational new drugs
Abbr.
Invest New Drugs
ISSN
0167-6997
Published
1984-00-00
Pages
351-7
Language
English
Region
United States
NLM ID
8309330
Subset
IM
Grants
NCI NIH HHS · CA-17094 · United States
NCI NIH HHS · CA-31078 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com